Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
SLMG Beverages Eyes Price Hikes Amid Rising Packaging Costs and India's Booming Soft Drink Market
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Global Flight Cancellations 2026: Middle East Air Travel Chaos Explained
Finnair Orders 18 Embraer E195-E2 Jets in Landmark Fleet Overhaul
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025 



